|
DNA highly-promising predictor for successful treatment of alcoholics
October 05, 2006According to Dutch researcher Wendy Ooteman, the biological and genetic characteristics of alcoholics can predict which drugs will best suppress the desire to drink. Naltrexone and acamprosate are drugs that are supposed to suppress the desire for a drink. The researcher investigated which patient characteristics were responsible for predicting the drug that would work best.
Alcoholics have an overwhelming urge to drink. That desire not only facilitates alcohol addiction but also ensures that the habit is difficult to kick. There are two drugs that can suppress this longing for alcohol: naltrexone works via the reward system in the brain and acamprosate via the stress system. However, they do not work for everybody. The question was whether patient characteristics can predict which drug works best for which patient.
Temptation
One hundred and fifty-six alcoholics were willing to participate in Ootemans' study. The participants' desire to drink was aroused by, for example, placing a glass of their favourite drink on the table. Meanwhile they were posed questions about their urge for a drink and their physical reactions were measured, such as heart rate and sweat production. Genetic characteristics were also determined. After a month of treatment with naltrexone, acamprosate or a placebo the effect of clinical, physiological or genetic differences on the success of the treatment was examined.
Genetic indications
Clinical patient characteristics were found to be a poor predictor of whether someone would respond best to acamprosate or naltrexone. Biological and genetic characteristics could, however, predict this. People who started to sweat profusely during the experiment, responded better to acamprosate, whereas people who sweated less profusely responded better to naltrexone. Further genes which code for certain receptors in the brain predicted which drug would be successful for a patient. In particular, the genes that code for the mu-opioid receptor, the dopamine D2 receptor and a gaba receptor were found to be good predictors. This might be because these genes are closely associated with the causes of addiction.
Further research
The question is whether these same results will be found if longer term relapse is examined. It is expected that in particular the highly-promising genetic characteristics will be used for a more effective allocation of alcoholics to different treatments.
Netherlands Organisation for Scientific Research
One hundred and fifty-six alcoholics were willing to participate in Ootemans' study. The participants' desire to drink was aroused by, for example, placing a glass of their favourite drink on the table. Meanwhile they were posed questions about their urge for a drink and their physical reactions were measured, such as heart rate and sweat production. Genetic characteristics were also determined. After a month of treatment with naltrexone, acamprosate or a placebo the effect of clinical, physiological or genetic differences on the success of the treatment was examined.
Genetic indications
Clinical patient characteristics were found to be a poor predictor of whether someone would respond best to acamprosate or naltrexone. Biological and genetic characteristics could, however, predict this. People who started to sweat profusely during the experiment, responded better to acamprosate, whereas people who sweated less profusely responded better to naltrexone. Further genes which code for certain receptors in the brain predicted which drug would be successful for a patient. In particular, the genes that code for the mu-opioid receptor, the dopamine D2 receptor and a gaba receptor were found to be good predictors. This might be because these genes are closely associated with the causes of addiction.
Further research
The question is whether these same results will be found if longer term relapse is examined. It is expected that in particular the highly-promising genetic characteristics will be used for a more effective allocation of alcoholics to different treatments.
Netherlands Organisation for Scientific Research
Alcoholic News and Current Alcoholic Events RSSDrug abuse accounts for a third of the deaths behind Scotland's higher mortality rate
Drug abuse accounts for a third of the deaths behind Scotland's higher mortality rate, according to a study published on bmj.com today.
Alcoholism-associated molecular adaptations in brain neurocognitive circuits
After many years of heavy drinking, alcohol produces pathological alterations in the brain. In many alcoholics these changes culminate in massive social deterioration and disorders of memory and learning.
The Internet, alcohol and sleep
Girls moving through adolescence may experience unhealthy levels of weight gain, but the reasons for this are not always clear. In fact, many potential causes of weight gain are easily overlooked. A new study soon to be published in The Journal of Pediatrics analyzes the effect of Internet usage, sleep, and alcohol and coffee consumption on weight gain in adolescent girls.
Minimum drinking age of 21 saves lives
One of the most comprehensive studies on the minimum drinking age shows that laws aimed at preventing consumption of alcohol by those under 21 have significantly reduced drinking-related fatal car crashes.
Kids connect alcohol odors with mom's emotions
How children respond to the smell of alcoholic beverages is related to their mothers' reasons for drinking, according to a new study from the Monell Chemical Senses Center.
Memory loss linked to common sleep disorder
For the first time, UCLA researchers have discovered that people with sleep apnea show tissue loss in brain regions that help store memory.
New research links smoking and body mass index to hearing loss
Smoking and body mass index (BMI) are risk factors in the development of age-related hearing loss, says one of the largest-ever studies into risk factors for hearing loss - but alcohol has a protective effect.
Fatty liver linked to increased risk of diabetic kidney disease
For patients with type 2 diabetes, a condition called non-alcoholic fatty liver disease (NAFLD) may be an important risk factor for diabetes-related chronic kidney disease (CKD), according to a study in the August Journal of the American Society of Nephrology (JASN).
Risk threshold of daily alcohol intake and drinking duration in liver injury?
Alcoholic threshold effect rather than a dose-response effect on mortality from alcohol-related liver injury. Alcohol intake, rather than the type of alcoholic beverage, was more significant to liver injury.
Study finds 21st birthday binge drinking extremely common; can pose serious health hazards
The "21 for 21" ritual, where 21st birthday revelers attempt to down 21 alcoholic drinks, is highly prevalent among college students, according to new research.
More Alcoholic News Articles
 | The Glass Castle: A Memoir by Jeannette Walls |
 | A Wolf at the Table: A Memoir of My Father by Augusten Burroughs |
 | A Child Called "It": One Child's Courage to Survive by Dave Pelzer |
 | Everyday Drinking: The Distilled Kingsley Amis by Kingsley Amis |
 | The Lost Boy: A Foster Child's Search for the Love of a Family by Dave Pelzer |
 | Alcoholics Anonymous - Big Book 4th Edition by AA Services |
 | Windows on the World Complete Wine Course: 2008 Edition (Windows on the World Complete Wine Course) by Kevin Zraly |
 | A Man Named Dave by Dave Pelzer |
 | Courageous Souls: Do We Plan Our Life Challenges Before Birth? by Robert Schwartz |
 | Adult Children of Alcoholics by Janet G. Woititz |
| © 2008 BrightSurf.com |